Penn was highlighted in The Daily Pennsylvanian for ranking first in annual licensing income among 153 research institutions.
The article notes that since PCI’s establishment in 2014, the amount of corporate-sponsored research funding for Penn faculty and commercial agreements has majorly increased, yielding over 700 executed commercial agreements per year with established companies and startups.
Additionally, The Daily Pennsylvania recognized Penn’s wide variety of spinout companies, which exist across different industries, including robotics and autonomous vehicles, cancer, immunology and infectious diseases, digital medicine, energy storage, and nanotechnology. The biggest industry has been cell and gene therapy, with Penn spinning out nearly 50 cell and gene therapy startups in the greater Philadelphia region. All of these Penn-affiliated companies have helped to attract venture capital and create new jobs in the region.
Read the full article here.